Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene Hart

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Bioorganic Chemistry|August 2, 2024
Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agentsYao Cheng, John Patrick Jones, Tsz Tin Yu, et al.
Bioorganic Chemistry|August 20, 2024
Corrigendum to "Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agents" [Bioorg. Chem. 151 (2024) 107665]Yao Cheng, John Patrick Jones, Tsz Tin Yu, et al.
Science Advances|March 13, 2026
The <i>Plasmodium falciparum</i> PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogsXiangning Liu, Ruitao Jin, Riyad Domingo, et al.
Journal of the National Cancer Institute. Monographs|November 17, 2005
Building a virtual cancer research organizationMark C Hornbrook, Gene Hart, Jennifer L Ellis, et al.
Redox Biology|November 20, 2019
Phenotypic screen for oxygen consumption rate identifies an anti-cancer naphthoquinone that induces mitochondrial oxidative stressFrances L Byrne, Ellen M Olzomer, Gabriella R Marriott, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Bioorganic Chemistry|August 2, 2024
Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agentsYao Cheng, John Patrick Jones, Tsz Tin Yu, et al.
Bioorganic Chemistry|August 20, 2024
Corrigendum to "Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agents" [Bioorg. Chem. 151 (2024) 107665]Yao Cheng, John Patrick Jones, Tsz Tin Yu, et al.
Science Advances|March 13, 2026
The <i>Plasmodium falciparum</i> PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogsXiangning Liu, Ruitao Jin, Riyad Domingo, et al.
Journal of the National Cancer Institute. Monographs|November 17, 2005
Building a virtual cancer research organizationMark C Hornbrook, Gene Hart, Jennifer L Ellis, et al.
Redox Biology|November 20, 2019
Phenotypic screen for oxygen consumption rate identifies an anti-cancer naphthoquinone that induces mitochondrial oxidative stressFrances L Byrne, Ellen M Olzomer, Gabriella R Marriott, et al.
Pageof 7